Cite
MLA Citation
M Bartoletti et al.. “EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis.” International journal of gynecological cancer, vol. 29, n.d., pp. A437–A438. http://access.bl.uk/ark:/81055/vdc_100144714284.0x000019